Targeting SPP1 requires moving beyond ligand blockade

Affiliations

• ¹ Institute for Data-Driven Tumor Immunology, Chongqing Medical University, Chongqing, China.
• ² Institute for Data-Driven Tumor Immunology, Chongqing Medical University, Chongqing, China. zemin@pku.edu.cn.
• ³ Biomedical Pioneering Innovation Center (BIOPIC), Academy for Advanced Interdisciplinary Studies, and School of Life Sciences, Peking University, Beijing, China. zemin@pku.edu.cn.